Physician profile
Nancy L Beck
NPI 1124205513
$1,053.56
in general payments reported to CMS, 2019-2025
16 companies · $79.04 in 2025
The $79.04 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $81.68 · 2022: $136 · 2023: $381 · 2024: $258 · 2025: $79.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $361.81 | 2022-2025 | Omnipod |
| Dexcom, INC. | $134.91 | 2019-2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $91.59 | 2024 | |
| Tandem Diabetes Care, INC. | $88.25 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $51.62 | 2023 | |
| Lilly USA, LLC | $50.89 | 2020 | |
| Chiesi USA, INC. | $47.40 | 2020-2024 | Myalept |
| Medtronic, INC. | $46.83 | 2023 | Minimed 780g |
| Sanofi-Aventis U.S. LLC | $39.68 | 2024 | |
| Abbott Laboratories | $35.73 | 2023-2024 | Freestyle Libre 3 |
| Tolmar, INC. | $25.72 | 2023 | |
| Atricure, INC. | $24.75 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Biomarin Pharmaceutical INC. | $19.00 | 2023 | Voxzogo 1.2mg |
| Pfizer INC. | $18.16 | 2025 | |
| Medtronic Minimed, INC. | $17.22 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.